Navigation Links
ClariVein(TM) Catheter for Varicose Veins: Further Clinical Trial Results to Be Presented
Date:9/18/2009

MADISON, Conn., Sept 18 /PRNewswire/ -- Further results from the initial clinical trial of the ClariVein(TM) catheter, used in a new minimally invasive treatment for varicose veins, will be delivered on Friday, September 25, at the 23rd Annual Meeting of the Eastern Vascular Society in Philadelphia. The device combines mechanical and chemical modalities to accomplish vein treatment in an in-office setting.

Speaking is Steve Elias MD FACS FACPh, Associate Professor of Surgery at Mount Sinai Hospital, NY and the Director of The Centers for Vein Disease at Mount Sinai and Englewood Hospitals. Dr. Elias is the principle investigator of the trial, which was conducted at Englewood Hospital and Medical Center, NJ. Thirty patients were studied in this IRB-regulated trial.

"Initial results were very encouraging, and the success rates continue to be excellent as we follow patients over a longer period," Dr. Elias states. "The success rates are equal to the early results of radiofrequency or laser treatment of great saphenous vein disease. The main advantage is that the technique does not require tumescence anesthesia infusion, thus saving significant time and decreasing patient discomfort. In addition, no generator is required and capital and maintenance cost is reduced. This in-office procedure takes about 15 minutes to perform and patients resume normal activity that day. All patients would recommend the procedure to others."

The ClariVein(TM) catheter is a product of Vascular Insights LLC (http://vascularinsights.com) of Madison, CT. The company engages in the design, development, manufacture, and marketing of medical devices for the minimally invasive treatment of peripheral vascular disease. The company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ClariVein(TM) for infusion of physician-specified agents in the peripheral vasculature.

Dr. Elias is scheduled to speak at the 10:00 am scientific session at the Loews Philadelphia Hotel.

    Contact:

    Bill Kelly
    HarveyMalis Communications LLC
    bill@harveymalis.com
    203-375-2696


'/>"/>
SOURCE Vascular Insights LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ClariVein(TM) Catheter for Varicose Veins: Clinical Trial Results to be Presented
2. InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundations (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting
3. 2,500 Cases Completed With the Magnetic Irrigated Catheter
4. Iontophoretic Drug Delivery System (IDDS) Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in a Phase 2 Clinical Trial
5. New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation
6. Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013
7. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
8. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
9. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
10. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
11. Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 Glycotope GmbH, ... today announces the appointment of Dr. Alfredo Zurlo ... is an oncologist with many years clinical experience and ... industries. His last role was at Mologen AG where ... Executive Board. Previously Dr. Zurlo held various positions at ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
(Date:4/28/2016)... April 28, 2016 ... George Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter ... heute bekannt, dass neue Führungskräfte zum Team ... sind, die vielfältige Erfahrungen mitbringen.  Dies wird ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... 03, 2016 , ... Huntington Beach orthopedic doctor , Dr. Rick Pospisil, ... be used to diagnose and treat joint problems. During this procedure, Dr. Pospisil makes ... special lighting system and lens that illuminate and magnify the various structures in the ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Finding the right way to address a patient’s ... healthcare industry is now getting on board. , “You do the right thing, at the ... of care goes down, not up,” said Leonard M. Fromer, MD, FAAFP, from Group Practice ...
(Date:5/3/2016)... ... ... Dave Newberry, broker/owner of Newberry Realty, recently announced his office will be ... Friday, May 20. “We have raised over $1,000 for the table to support this ... PICC is a local Kent, WA, clinic that cares for drug-exposed babies and medically ...
(Date:5/2/2016)... ... 02, 2016 , ... It has just been announced Jack Uldrich, ... throughout the month of May. , Uldrich is the author of 11 books and ... frequently appears on the Science Channel’s FutureScape and Discovery Channel’s Inside Out. , Known ...
(Date:5/2/2016)... PA (PRWEB) , ... May 02, 2016 , ... As ... Healthsystem Association of Pennsylvania (HAP) issues its full support to allow certified nurse practitioners ... physician supervision after they have worked under such supervision for three years and 3,600 ...
Breaking Medicine News(10 mins):